Daxas News
Most Popular Daxas Story
FDA panel rejects Forest, Nycomed drug Daxas for COPD
In a 10-5 decision, an FDA expert panel voted against approval Daxas, Forest Laboratories and Nycomed's drug for chronic obstructive pulmonary disorder (COPD). The panel did vote 9-6 that the drug is Read more...
Latest Headlines
- July 6, 2010
- May 18, 2010
- April 26, 2010
- August 28, 2009
- August 10, 2009
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
